EUVIMEDEUVIMED entdecken
Crossref

Double‐reporter‐guided targeted activation of the oxytetracycline silent gene cluster in Streptomyces rimosus M527

Yue Shi, Jinyao Zhang, Zheng Ma iD, Yongyong Zhang, Andreas Bechthold, Xiaoping Yu

Biotechnology and Bioengineering · 2023

DOI: 10.1002/bit.28347 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology and Bioengineering, 2023. Verfasst von Yue Shi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Provincial Key Laboratory of Biometrology and Inspection & Quarantine, College of Life Sciences, China Jiliang University, Hangzhou, Zhejian…. Hauptthemen laut MEDLINE: Oxytetracycline, Streptomyces rimosus. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 63 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In Streptomyces rimosus M527, the oxytetracycline (OTC) biosynthetic gene cluster is not expressed under laboratory conditions. In this study a reported‐guided mutant selection (RGMS) procedure was used to activate the cluster. The double‐reporter plasmid pAGT was constructed in which gusA encoding a β‐glucuronidase and tsr encoding a thiostrepton resistance methyltransferase were placed under the control of the native promoter of oxyA gene (P oxyA ). Plasmid pAGT was introduced and integrated into the chromosome of S. rimosus M527 by conjugation, yielding initial strain M527‐pAGT. Subsequently, mutants of M527‐pAGT were generated by using ribosome engineering technology. The mutants harboring activated OTC gene cluster were selected based on visual observation of GUS activity and thiostrepton resistance. Finally, mutant M527‐pAGT‐R7 was selected producing OTC in a concentration of 235.2 mg/L. In this mutant transcriptional levels of oxy sr genes especial oxyA sr gene were increased compared to wild‐type strain S. rimosus M527. The mutant M527‐pAGT‐R7 showed antagonistic activities against Gram‐negative and Gram‐positive strains. All data indicate that the OTC gene cluster was successfully activated using the RGMS method.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OxytetracyclineStreptomyces rimosusThiostreptonMultigene FamilyPromoter Regions, Genetic

Stichwörter der Autor:innen

Streptomyces rimosus M527activation of silent gene clusterdouble-reporter-guidedoxytetracyclineribosome engineering

Substanzen

OxytetracyclineThiostrepton

Autor:innen und Institutionen

  • Zhejiang Provincial Key Laboratory of Biometrology and Inspection & Quarantine, College of Life Sciences, China Jiliang University, Hangzhou, Zhejiang Province, China.
  • Institute for Pharmaceutical Sciences, Pharmaceutical Biology and Biotechnology, University of Freiburg, Freiburg, Germany.

ORCID-Profile: Zheng Ma

Zitieren

APA

Shi, Y., Zhang, J., Ma, Z., Zhang, Y., Bechthold, A., & Yu, X. (2023). Double‐reporter‐guided targeted activation of the oxytetracycline silent gene cluster in Streptomyces rimosus M527. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.28347

Vancouver

Shi Y, Zhang J, Ma Z, Zhang Y, Bechthold A, Yu X. Double‐reporter‐guided targeted activation of the oxytetracycline silent gene cluster in Streptomyces rimosus M527. Biotechnology and Bioengineering. 2023. doi:10.1002/bit.28347

BibTeX
@article{Shi2023,
  author = {Shi, Yue and Zhang, Jinyao and Ma, Zheng and Zhang, Yongyong and Bechthold, Andreas and Yu, Xiaoping},
  title = {Double‐reporter‐guided targeted activation of the oxytetracycline silent gene cluster in Streptomyces rimosus M527},
  journal = {Biotechnology and Bioengineering},
  year = {2023},
  doi = {10.1002/bit.28347}
}
Kostenlos starten →